Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.

被引:25
作者
Stone V.E. [1 ]
机构
[1] Massachusetts General Hospital, Bulfinch 130, 55 Fruit Street, Boston, 02114, MA
关键词
African American Patient; Minority Patient; Health Care Disparity; Provider Perception; Active Injection Drug;
D O I
10.1007/s11904-005-0015-5
中图分类号
学科分类号
摘要
Racial/ethnic minorities in the United States are disproportionately affected by HIV/AIDS. In addition to having higher rates of HIV/AIDS, minorities with HIV/AIDS have higher mortality rates than others in the United States. Disparities in the care received by minorities living with HIV/AIDS contribute to these higher mortality rates. This article provides a review of HIV/AIDS health care disparities and explores providers' contributions to these disparities. An important source of provider contribution to disparities appears to be differential prescribing based on perceptions and assumptions that minority patients may have lower adherence to highly active antiretroviral therapy. Literature regarding this topic is reviewed and strategies for reducing disparities are suggested.
引用
收藏
页码:189 / 193
页数:4
相关论文
共 98 条
[1]  
Wong MD(2002)Contribution of major diseases to disparities in mortality N Engl J Med 347 1585-1592
[2]  
Shapiro MF(1994)Racial differences in the use of drug therapy for HIV disease in an urban community N Engl J Med 330 763-768
[3]  
Boscardin WJ(1994)Changes in insurance status and access to care by persons with AIDS in the Boston Health Study Am J Public Health 84 1997-2000
[4]  
Ettner SL(1992)Variation in health service among HIV-infected patients Med Care 30 17-29
[5]  
Moore R(1999)Variations in the care of HIV-infected adults in the United States JAMA 281 2305-2315
[6]  
Stanton D(2000)Delayed medical care after diagnosis in a U.S. national probability sample of persons infected with HIV Arch Intern Med 160 2614-2622
[7]  
Gopalan R(2000)Differential access in the receipt of antiretroviral drugs for the treatment of AIDS and its implications for survival Arch Intern Med 160 3114-3120
[8]  
Chaisson RE(2001)initiation and continuation of newer antiretroviral treatments among Medicaid recipients with AIDS J Gen Intern Med 16 850-859
[9]  
Weissman JS(2004)Does racial concordance between HIV-positive patients and their physicians affect the time to receipt of protease inhibitors J Gen Intern Med 19 1146-1153
[10]  
Makadon HI(2000)Access of vulnerable groups to antiretroviral therapy among persons in care for HIV disease in the U.S Health Serv Res 35 389-416